INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,348,440 | +4.4% | 1,914,802 | -12.8% | 0.03% | +10.3% |
| Q2 2023 | $46,317,842 | +6.1% | 2,195,188 | -14.3% | 0.03% | 0.0% |
| Q1 2023 | $43,666,091 | -27.1% | 2,561,169 | -14.5% | 0.03% | -32.6% |
| Q4 2022 | $59,863,004 | -18.9% | 2,996,252 | -56.2% | 0.04% | -21.8% |
| Q3 2022 | $73,770,697 | -46.6% | 6,842,652 | -2.3% | 0.06% | -42.1% |
| Q2 2022 | $138,051,000 | -23.5% | 7,000,337 | -8.8% | 0.10% | +9.2% |
| Q1 2022 | $180,442,000 | -16.0% | 7,678,266 | -2.6% | 0.09% | -3.3% |
| Q4 2021 | $214,700,000 | -2.4% | 7,881,558 | -1.3% | 0.09% | -6.2% |
| Q3 2021 | $219,985,000 | -2.8% | 7,987,899 | +0.5% | 0.10% | -1.0% |
| Q2 2021 | $226,317,000 | +6.9% | 7,952,001 | +27.9% | 0.10% | 0.0% |
| Q1 2021 | $211,808,000 | +9.3% | 6,218,576 | +6.8% | 0.10% | +7.8% |
| Q4 2020 | $193,831,000 | -2.2% | 5,822,413 | -5.6% | 0.09% | -12.6% |
| Q3 2020 | $198,278,000 | -22.1% | 6,169,167 | -33.3% | 0.10% | -28.0% |
| Q2 2020 | $254,534,000 | +79.8% | 9,242,372 | +4.7% | 0.14% | +47.4% |
| Q1 2020 | $141,566,000 | -49.2% | 8,831,356 | -24.3% | 0.10% | -32.2% |
| Q4 2019 | $278,614,000 | +30.3% | 11,667,278 | -3.7% | 0.14% | +23.3% |
| Q3 2019 | $213,807,000 | -28.4% | 12,120,579 | +3.9% | 0.12% | -28.4% |
| Q2 2019 | $298,603,000 | -9.1% | 11,664,190 | +3.2% | 0.16% | -11.0% |
| Q1 2019 | $328,562,000 | +119.3% | 11,302,434 | -1.0% | 0.18% | +89.6% |
| Q4 2018 | $149,850,000 | -20.4% | 11,421,461 | +22.7% | 0.10% | -5.0% |
| Q3 2018 | $188,154,000 | +6.7% | 9,305,332 | +24.8% | 0.10% | +1.0% |
| Q2 2018 | $176,309,000 | +25.3% | 7,454,938 | +19.3% | 0.10% | +20.5% |
| Q1 2018 | $140,668,000 | -24.3% | 6,246,342 | +4.7% | 0.08% | -27.2% |
| Q4 2017 | $185,933,000 | +50.4% | 5,963,206 | +50.6% | 0.11% | +44.3% |
| Q3 2017 | $123,615,000 | +336.9% | 3,960,748 | +140.2% | 0.08% | +315.8% |
| Q2 2017 | $28,292,000 | +1713.6% | 1,648,703 | +2098.3% | 0.02% | +58.3% |
| Q1 2015 | $1,560,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,533,883 | $44,590,000 | 16.02% |
| Foresite Capital Management II, LLC | 919,436 | $26,728,000 | 12.07% |
| NEXTHERA CAPITAL LP | 284,263 | $8,264,000 | 10.03% |
| Palo Alto Investors LP | 7,653,617 | $222,491,000 | 9.28% |
| Asymmetry Capital Management, L.P. | 154,887 | $4,503,000 | 7.52% |
| ACUTA CAPITAL PARTNERS, LLC | 370,000 | $10,756,000 | 5.11% |
| Vivo Capital, LLC | 1,170,290 | $34,020,000 | 3.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 110,000 | $3,198,000 | 1.18% |
| Islet Management, LP | 350,000 | $10,175,000 | 1.18% |
| EMERALD ADVISERS, LLC | 921,527 | $26,789,000 | 1.09% |